NCT00943852View on ClinicalTrials.gov

The Effect of Losartan and Losartan Plus Isosorbide Mononitrate on Central Blood Pressure Measurements (0954-317)

PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions
Hypertension
Interventions
DRUG

losartan potassium

Single dose losartan 100 mg in one of five treatment periods

DRUG

Comparator: isosorbide mononitrate (ISMN)

Single dose ISMN 60 mg in one of five treatment periods

DRUG

Comparator: losartan + ISMN

Single dose losartan 100 mg and ISMN 15 mg in one of five treatment periods

DRUG

Comparator: losartan + ISMN

Single dose losartan 100 mg and ISMN 60 mg in one of five treatment periods

DRUG

Comparator: Placebo

Single dose placebo only in one of five treatment periods

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00943852 - The Effect of Losartan and Losartan Plus Isosorbide Mononitrate on Central Blood Pressure Measurements (0954-317) | Biotech Hunter | Biotech Hunter